Joseph A Akers insider trades: Titan Pharmaceuticals (TTNP) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Joseph reports to the SEC
Open-market buys and sales
2 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Sep 21, 2018 | TTNP | ↑ Buy | 200,000 | $0.25 | $50K | Direct | Sep 25, 2018 (4d) |
| Jul 19, 2016 | TTNP.OB | ↑ Buy | 13,000 | $4.85 | $63K | Direct | Jul 19, 2016 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Joseph A Akers's insider trades
Joseph A Akers is a director at Titan Pharmaceuticals (TTNP). Since Jul 19, 2016, Joseph has reported 2 open-market purchases worth $113K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (8 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every TTNP insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.